Qualitas says drawbacks of open pond algae cultivation easily dealt with

By Hank Schultz contact

- Last updated on GMT

Related tags: Eicosapentaenoic acid, Algae

Qualitas Health, a supplier of a unique polar-lipid structured algal omega-3 ingredient, is now at full scale production and is participating in what an executive calls “the future of omega-3s.”

Qualitas is based in Jerusalem, Israel, but has its production facility in West Texas, where sunlight is abundant and a brackish water supply is available. Qualitas chose a phototrophic process mainly because it matched its organism, which yields high levels of EPA in an oil that has a unique phospholipid-glycolipid structure. Other entrants into the algal omega-3s space have opined that heterotrophic (fermentation) production is the only proven way to go, and that open ponds are too subject to contamination events that can interrupt the flow of ingredients.

David Hart, vice president of marketing for Qualitas, counters that heterotrophic technology is very capital intensive and requires pricy inputs in terms of energy and feedstocks. Open ponds have their drawbacks, but they can be dealt with, he told NutraIngredients-USA at the Expo West trade show in Anaheim, CA.

“We grow the algae in open ponds, so sunlight is the source of energy. It is an agricultural technology, so you are at the mercy of the elements. But there are ways to mitigate that by holding inventories of different intermediates, whether it is the harvested algae or the extracted oil,”​ he said.

Hart said that Qualitas is well positioned to participate in the global growth of the omega-3s market with an ingredient that has sustainability advantages over marine sources.

 “The future is definitely in algae.  It is much more sustainable,”​ he said.

Related news

Show more

Related products

show more

High-Quality CBD Ingredients for Every Formulation

High-Quality CBD Ingredients for Every Formulation

Mile High Labs | 27-Mar-2019 | Technical / White Paper

Mile High Labs' CBD is the key ingredient found in the industry’s most recognized products. Our CBD isolate is extracted in a highly controlled environment...

MenaQ7® K2: Patent Protection, Confirmed Benefits

MenaQ7® K2: Patent Protection, Confirmed Benefits

NattoPharma USA, Inc. | 25-Mar-2019 | Data Sheet

Vitamin K2 is the new cardio-support nutrient because clinical studies have confirmed it delivers what no other compound can: reduction in arterial stiffening.

Resveratrol & Cognition: a Winning Combination

Resveratrol & Cognition: a Winning Combination

Evolva | 25-Mar-2019 | Infographic

Brain health is top of mind for consumers, and research indicates that resveratrol can be effective in maintaining memory, processing, and reasoning that...

Related suppliers

Follow us

Featured Events

View more

Products

View more

Webinars